Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Shares Outstanding (2017 - 2025)

Selectis Health's Shares Outstanding history spans 13 years, with the latest figure at $200500.0 for Q3 2025.

  • For Q3 2025, Shares Outstanding fell 93.46% year-over-year to $200500.0; the TTM value through Sep 2025 reached $200500.0, down 93.46%, while the annual FY2024 figure was $375000.0, 0.0% changed from the prior year.
  • Shares Outstanding for Q3 2025 was $375000.0 at Selectis Health, up from $200500.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $3.1 million in Q3 2024 and bottomed at $200500.0 in Q1 2021.
  • The 5-year median for Shares Outstanding is $200500.0 (2021), against an average of $688538.6.
  • The largest annual shift saw Shares Outstanding tumbled 99.27% in 2021 before it soared 1429.71% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $375000.0 in 2021, then changed by 0.0% to $375000.0 in 2022, then crashed by 46.53% to $200500.0 in 2023, then surged by 87.03% to $375000.0 in 2024, then crashed by 46.53% to $200500.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Shares Outstanding are $200500.0 (Q3 2025), $375000.0 (Q2 2025), and $375000.0 (Q1 2025).